Barton Haynes
Barton F. Haynes is an American physician and research scientist who is known for basic work on biology of T cells and the thymus. It enabled curative thymic transplantation for babies born without a thymus (DiGeorge syndrome).Haynes is known also for the discovery of immune tolerance control of HIV neutralizing antibodies, for his elucidation of HIV-neutralizing antibody co-evolution, and for the discovery of a novel type of B cells in the natural antibody pool called Fab Dimerized Glycan (FDG) antibodies.
An infectious disease and clinical immunology and allergy specialist, Haynes is the founding director of the Duke Human Vaccine Institute (DHVI) and since 2005, has been an international leader in the development of an HIV vaccine. His basic and translational research has guided the work of his team and others in the field. He led the team that first induced HIV broadly reactive neutralizing antibody lineages in humans with a vaccine. He has performed work on HIV-host interactions that have led to strategies for HIV vaccine development and, more generally, concepts for engineering the B cell arm of the immune system [13, 14]. Haynes' team played an active role in the response to COVID-19 by co-developing new vaccines for pre-emergent coronaviruses. Provided by Wikipedia
-
1